Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METFORMIN\ROSIGLITAZONE: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

41.4%
Female
58.6%
Male

Age Information

The average age of patients reporting adverse events with METFORMIN\ROSIGLITAZONE is 58.2 years.

Geographic Distribution

The majority of adverse event reports for METFORMIN\ROSIGLITAZONE originate from COUNTRY NOT SPECIFIED.

Report Summary & Outcomes

4,637
Total Reports
4,637
As Primary/Secondary Suspect
395
Deaths Reported
3,271
Hospitalizations
1
Life-Threatening
7
Disabilities

Reporting Timeline

First adverse event report: 19940110. Most recent report: 201312. View full timeline →

More About METFORMIN\ROSIGLITAZONE

METFORMIN\ROSIGLITAZONE Full Profile Reports by Year Drug Interactions